curasafehealthcare.com
  • Home
  • About
  • Services
  • Therapeutic Areas
  • Careers
  • Latest News
  • Contact Us
Select Page

Comparison of One-Step and Two-Step Light Curing of Bonding Agents and Composite in Orthodontics

by palligoelme@gmail.com | Mar 24, 2026 | Clinical Trials

​ Conditions: Orthodontic Treatment; Bracket Failure Interventions: Procedure: One step light curing of bonding agent and composite; Procedure: Two step light curing of bonding agent and composite Sponsors: Shaheed Zulfiqar Ali Bhutto Medical University...

Intestinal Microbiota Transplantation in Patients With Chronic Heart Failure

by palligoelme@gmail.com | Mar 24, 2026 | Clinical Trials

​ Conditions: Chronic Heart Failure Interventions: Biological: MTP-101-C encapsulated Microbiota; Drug: Vancomycin; Drug: Neomycin Sponsors: Melana Yuzefpolskaya, MD Recruiting Conditions: Chronic Heart Failure Interventions: Biological: MTP-101-C encapsulated...

Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

by palligoelme@gmail.com | Mar 24, 2026 | Clinical Trials

​ Conditions: Hypofractionated Dose; Prostate Cancer Patients Interventions: Radiation: Hypofractionated Intensity-Modulated Radiation Therapy; Radiation: Conventional Intensity-Modulated Radiation Therapy Sponsors: Tanta University Completed Conditions:...

To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants

by palligoelme@gmail.com | Mar 24, 2026 | Clinical Trials

​ Conditions: Healthy Children Interventions: Dietary Supplement: Probiotic; Dietary Supplement: Placebo Sponsors: Min-Tze LIONG; Shanghai 6th People’s Hospital Recruiting Conditions: Healthy Children Interventions: Dietary Supplement: Probiotic; Dietary...

IMPULS-NRW: Telemedicine in Specialized Outpatient Palliative Care

by palligoelme@gmail.com | Mar 24, 2026 | Clinical Trials

​ Conditions: End of Life; Palliative Patients; Outpatient Treatment Interventions: Behavioral: IMPULS-NRW Sponsors: University Hospital Muenster Active, not recruiting Conditions: End of Life; Palliative Patients; Outpatient Treatment Interventions: Behavioral:...

A Study to Test How BI 3000202 is Taken up in the Blood of People With and Without Liver Problems

by palligoelme@gmail.com | Mar 24, 2026 | Clinical Trials

​ Conditions: Healthy; Hepatic Impairment Interventions: Drug: BI 3000202 Sponsors: Boehringer Ingelheim Not yet recruiting Conditions: Healthy; Hepatic Impairment Interventions: Drug: BI 3000202 Sponsors: Boehringer Ingelheim Not yet...
« Older Entries
Next Entries »

Recent Posts

  • Development and Clinical Evaluation of a Novel Hollow Cusp Fracture Reducer for Femoral Shaft and Patellar Fractures
  • Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo
  • The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents – the PpUF-study.
  • Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.
  • [Trial of device that is not approved or cleared by the U.S. FDA]

Recent Comments

No comments to show.

Curasafe healthcare solutions Pvt. Ltd. provides comprehensive services including safety program oversight, risk management, and regulatory compliance.

Important Links

  • Home
  • Contact Us
Connect With Us

Contact


711, Shivalik Satyamev, Bopal Ambli Junction, Bopal, Ahmedabad, Daskroi, Gujarat, India, 380058.


info@curasafehealthcare.com



(+91) 97803 81065

Copyright © 2025 Curasafehealthcare ®